Log In
Print
BCIQ
Print
Print this Print this
 

PEG-IFN lambda (PEG-interferon lambda) (PEG-rIL-29)

  Manage Alerts
Collapse Summary General Information
Company Bristol-Myers Squibb Co.
DescriptionRecombinant IL-29
Molecular Target Interleukin-29 (IL-29) (IFNL1)
Mechanism of ActionAntiviral agent
Latest Stage of DevelopmentPhase III
IndicationHepatitis C virus (HCV)
Partner

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today